PubMed HealthSearch

PubMed · 9357709

A decision analytic method for scoring performance on computer-based patient simulations.

Abstract

As computer based clinical case simulations become increasingly popular for training and evaluating clinicians, approaches are needed to evaluate a trainee's or examinee's solution of the simulated cases. We developed a decision analytic approach to scoring performance on computerized patient case simulations. We developed decision models for computerized patient case simulations in four specific domains in the field of infectious disease. The decision models were represented as influence diagrams. A single decision node represents the possible diagnoses the user may make. One chance node represents a probability distribution over the set of competing diagnoses in the simulations. The value node contains the utilities associated with all possible combinations of diagnosis and disease. All relevant data that the user may request from the simulation are represented as chance nodes with arcs to or from the diagnosis node and/or each other. Probabilities in the decision model were derived from the literature, where available, or expert opinion. Utilities were assessed by standard gamble from clinical experts. The process of solving computer based patient simulations involves repeated cycles of requesting data (history, physical examination or laboratory) and receiving these data from the simulations. Each time the user requests clinical data from the simulation, the influence diagram is evaluated with and without an arc from the corresponding chance node to the decision node. The difference in expected utility between the two solutions of the influence diagram represents the expected value of information (VOI) from the requested clinical datum. The ratio of the expected VOI from the data requested and the expected value of perfect information about the diagnosis is a normative measure of the quality of each of the user's data requests. This approach provides a continuous measure of the quality of the user's data requests in a way that is sensitive to the previous data collected. The score distinguishes serious from minor misdiagnoses. And the same influence diagram can be used to evaluate performance on multiple simulations in the same clinical domain.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S M Downs, C P Friedman, F Marasigan, G Gartner. 1997. A decision analytic method for scoring performance on computer-based patient simulations.. https://pubmed.ncbi.nlm.nih.gov/9357709/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Generating correlated data for omics simulation.

Simulation of realistic omics data is a key input for benchmarking studies that help users obtain optimal computational pipelines. Omics data involves large numbers of measured features on each sample and these measures are generally correlated with each other. However, simulation too often ignores these correlations, perhaps due to computational and statistical hurdles of doing so. To alleviate this, we describe three approaches for generating omics-scale data with correlated measures which mimic real datasets. These approaches are all based on a Gaussian copula approach with a covariance matrix that decomposes into a diagonal part and a low-rank part. This decomposition allows for extremely efficient simulation, overcoming a hurdle for adoption of past methods. We use these approaches to demonstrate the importance of including correlation in two benchmarking applications. First, we show that variance of results from the popular DESeq2 method increases when dependence is included. Second, we demonstrate that CYCLOPS, a method for inferring circadian time of collection from transcriptomics, improves in performance when given gene-gene dependencies in some circumstances. We provide an R package, dependentsimr, that has efficient implementations of these methods and can generate dependent data with arbitrary marginal distributions, including discrete (binary, ordered categorical, Poisson, negative binomial), continuous (normal), or with an empirical distribution.

Computer Simulation

Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.

The goal of cancer immunotherapy is to boost a patient's immune response to a tumour. Yet, the design of an effective immunotherapy is complicated by various factors, including a potentially immunosuppressive tumour microenvironment, immune-modulating effects of conventional treatments and therapy-related toxicities. These complexities can be incorporated into mathematical and computational models of cancer immunotherapy that can then be used to aid in rational therapy design. In this review, we survey modelling approaches under the umbrella of the major challenges facing immunotherapy development, which encompass tumour classification, optimal treatment scheduling and combination therapy design. Although overlapping, each challenge has presented unique opportunities for modellers to make contributions using analytical and numerical analysis of model outcomes, as well as optimization algorithms. We discuss several examples of models that have grown in complexity as more biological information has become available, showcasing how model development is a dynamic process interlinked with the rapid advances in tumour-immune biology. We conclude the review with recommendations for modellers both with respect to methodology and biological direction that might help keep modellers at the forefront of cancer immunotherapy development.

Computer Simulation

Coevolving protein residues: maximum likelihood identification and relationship to structure.

The identification of protein sites undergoing correlated evolution (coevolution) is of great interest due to the possibility that these pairs will tend to be adjacent in the three-dimensional structure. Identification of such pairs should provide useful information for understanding the evolutionary process, predicting the effects of site-directed substitution, and potentially for predicting protein structure. Here, we develop and apply a maximum likelihood method with the aim of improving detection of coevolution. Unlike previous methods which have had limited success, this method allows for correlations induced by phylogenetic relationships and for variation in rate of evolution along branches, and does not rely on accurate reconstruction of ancestral nodes. In order to reduce the complexity of coevolutionary relationships and identify the primary component of pairwise coevolution between two sites, we reduce the data to a two-state system at each site, regardless of the actual number of residues observed at that site. Simulations show that this strategy is good at identifying simple correlations and at recognizing cases in which the data are insufficient to distinguish between coevolution and spurious correlations. The new method was tested by using size and charge characteristics to group the residues at each site, and then evaluating coevolution in myoglobin sequences. Grouping based on physicochemical characteristics allows categorization of coevolving sites into positive and negative coevolution, depending on the correlation between equilibrium state frequencies. We detected a striking excess of negative coevolution (corresponding to charge) at sites brought into proximity by the periodicity of the alpha-helix, and there was also a tendency for sites with significant likelihood ratios to be close in the three-dimensional structure. Sites on the surface of the protein appear to coevolve both when they are close in the structure, and when they are distant, implying a role for folding and/or avoidance of quaternary structure in the coevolution process.

Computer Simulation